Balkan Journal of Medical Genetics

INHERITED THROMBOPHILIAS COULD INFLUENCE THE REPRODUCTIVE OUTCOME IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS
robeva r1,*, Tanev D2, andonova S3, Nikolova M4, Tomova a1, Kumanov Ph1, Savov a3, Rashkov R2, Kolarov Zl2,*
*Corresponding Author: Professor Zlatimir Kolarov, M.D., Ph.D., D.MSc., Clinic of Rheumatology, Medical University Sofia, 13 Urvich Str., Sofia 1612, Bulgaria. Tel: +359-2-958-93-91. Fax. +359-2-958-23-31. E-mail: zkolarov@abv.bg and Ralitsa Robeva, M.D., Ph.D., Clinical Center of Endocrinology and Gerontology, Medical University Sofia, 2 Zdrave Str., Sofia 1431, Bulgaria. Tel: +359-2-895-60-40. Fax: +359-2-987-41-45. E-mail: rali_robeva@yahoo.com
page: 21

REFERENCES

1. Dhar P, Sokol R. Thrombophilia in systemic lupus erythematosus: A review of multiple mechanisms and resultant clinical outcomes. In: Ivanov P, Ed. Pregnancy Thrombophilia – The Unsuspected Risk. INTECH, 2013 (http://dx.doi.org/10.5772/56902). 2. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and metaanalysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010; 5(11): 2060-2068. 3. Al Arfaj AS, Khalil N. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus. 2010; 19(14): 1665-1673. 4. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994; 369(6475): 64-67. 5. von Ahsen N, Lewczuk P, Schütz E, Oellerich M, Ehrenreich H. Prothrombin activity and concentration in healthy subjects with and without the prothrombin G20210A mutation. Thromb Res. 2000; 99(6): 549-556. 6. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: The result of a meta-analysis. Circulation. 1998; 98(23): 2520-2526. 7. Fijnheer R, Horbach DA, Donders RC, Vilé H, von Oort E, Nieuwenhuis HK, et al. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thromb Haemost. 1996; 76(4): 514-517. 8. Regéczy N, Lakos G, Balogh I, Ajzner E, Kiss E, Szegedi G. The Leiden mutation of coagulation factor V in Hungarian SLE patients. Clin Appl Thromb Hemost. 2000; 6(1): 41-45. 9. Vayá A, Santaolaria M, Micó L, Calvo J, Oropesa R, Villa P, et al. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects. Clin Hemorheol Microcirc. 2008; 40(2): 79-87. 10. Kaiser R, Barton JL, Chang M, Catanese JJ, Li Y, Begovich AB, et al. Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: A meta-analysis. Genes Immun. 2009; 10(5): 495-502. 11. Kaiser R, Li Y, Chang M, Catanese J, Begovich AB, Brown EE, et al. Genetic risk factors for thrombosis in systemic lupus erythematosus. J Rheumatol. 2012; 39(8): 1603-1610. 12. Brouwer JL, Bijl M, Veeger NJ, Kluin-Nelemans HC, van der Meer J. The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial throm-boembolism in patients with systemic lupus erythematosus. Blood. 2004; 104(1): 143-148. 13. Hochberg MC. Updating the american College of Rheumatology revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9): 1725. 14. Keeling D, Mackie I, Moore GW, Greer IA, Greaves M; British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012; 157(1): 47-58. 15. Koleva R, Dimitrova V, Chernev T, Savov A, Karagjozova Zh, Mazneykova V, et al. Impact of inherited thrombophilia on the development of some pregnancy complications. Akush Ginekol (Sofia). 2005; 44(5): 18-26. 16. Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, et al. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylene-tethraydrofolate reductase C677T: A meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol. 2013; 28(8): 621-647. 17. Bradley LA, Palomaki GE, Bienstock J, Varga E, Scott JA. Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes? Results from a targeted evidence-based review. Genet Med. 2012; 14(1): 39-50. 18. Tal J, Schliamser LM, Leibovitz Z, Ohel G, Attias D. a possible role for activated protein C resistance in patients with first and second trimester pregnancy failure. Hum Reprod. 1999; 14(6): 1624-1627. 19. Reznikoff-Etiévan MF, Cayol V, Carbonne B, Robert A, Coulet F, Milliez J. Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. BJOG 2001; 108(12): 1251-1254. 20. Preston FE, Rosendaal FR, Walker ID, Briët E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet. 1996; 348(9032): 913-916. 21. Spina V, Aleandri V, Morini F. The impact of the factor V Leiden mutation on pregnancy. Hum Reprod Update. 2000; 6(3): 301-306. 22. Meesters EW, Hansen H, Spronk HM, Hamulyak K, Rosing J, Rowshani AT, et al. The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus. Blood Coagul Fibrinolysis. 2007; 18(1): 21-28. 23. Demirci FY, Dressen AS, Kammerer CM, Barmada MM, Kao aH, ramsey-goldman r, et al. Functional polymorphisms of the coagulation factor II gene (F2) and susceptibility to systemic lupus erythematosus. J Rheumatol. 2011; 38(4): 652-657. 24. Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. a meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost. 2009; 102(2): 360-370. 25. Teng Z, Wang L, Cai S, Yu P, Wang J, Gong J, et al. The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: A meta-analysis based on 71 research studies. PLoS One 2013; 8(2):e55332. doi: 10.1371/journal. pone.0055332. 26. Afeltra A, Vadacca M, Conti L, Galluzzo S, Mitterhofer AP, Ferri GM, et al. Thrombosis in systemic lupus erythematosus: Congenital and acquired risk factors. Arthritis Rheum. 2005; 53(3): 452-459. 27. Summers CM, Cucchiara AJ, Nackos E, Hammons AL, Mohr E, Whitehead AS, et al. Functional polymorphisms of folate-metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus. J Rheumatol. 2008; 35(11): 2179-2186. 28. Wu X, Zhao L, Zhu H, He D, Tang W, Luo Y. Association between the MTHFR C677T polymorphism and recurrent pregnancy loss: A meta-analysis. Genet Test Mol Biomarkers. 2012; 16(7): 806-811. 29. Baumann K, Beuter-Winkler P, Hackethal A, Strowitzki T, Toth B, Bohlmann MK. Maternal factor V Leiden and prothrombin mutations do not seem to contribute to the occurrence of two or more than two consecutive miscarriages in Caucasian patients. Am J Reprod Immunol. 2013; 70(6): 518-521. 30. Ozdemir O, Yenicesu GI, Silan F, Köksal B, Atik S, Ozen F, et al. Recurrent pregnancy loss and its relation to combined parental thrombophilic gene mutations. Genet Test Mol Biomarkers. 2012; 16(4): 279-286.

Number 27 VOL. 27 (2), 2024	Number 27 VOL. 27 (1), 2024
Number 26 Number 26 VOL. 26(2), 2023 All in one	Number 26 VOL. 26(2), 2023
Number 26 VOL. 26, 2023 Supplement	Number 26 VOL. 26(1), 2023
Number 25 VOL. 25(2), 2022	Number 25 VOL. 25 (1), 2022
Number 24 VOL. 24(2), 2021	Number 24 VOL. 24(1), 2021
Number 23 VOL. 23(2), 2020	Number 22 VOL. 22(2), 2019
Number 22 VOL. 22(1), 2019	Number 22 VOL. 22, 2019 Supplement
Number 21 VOL. 21(2), 2018	Number 21 VOL. 21 (1), 2018
Number 21 VOL. 21, 2018 Supplement	Number 20 VOL. 20 (2), 2017
Number 20 VOL. 20 (1), 2017	Number 19 VOL. 19 (2), 2016
Number 19 VOL. 19 (1), 2016	Number 18 VOL. 18 (2), 2015
Number 18 VOL. 18 (1), 2015	Number 17 VOL. 17 (2), 2014
Number 17 VOL. 17 (1), 2014	Number 16 VOL. 16 (2), 2013
Number 16 VOL. 16 (1), 2013	Number 15 VOL. 15 (2), 2012
Number 15 VOL. 15, 2012 Supplement	Number 15 Vol. 15 (1), 2012
Number 14 14 - Vol. 14 (2), 2011	Number 14 The 9th Balkan Congress of Medical Genetics
Number 14 14 - Vol. 14 (1), 2011	Number 13 Vol. 13 (2), 2010
Number 13 Vol.13 (1), 2010	Number 12 Vol.12 (2), 2009
Number 12 Vol.12 (1), 2009	Number 11 Vol.11 (2),2008
Number 11 Vol.11 (1),2008	Number 10 Vol.10 (2), 2007
Number 10 10 (1),2007	Number 9 1&2, 2006
Number 9 3&4, 2006	Number 8 1&2, 2005
Number 8 3&4, 2004	Number 7 1&2, 2004
Number 6 3&4, 2003	Number 6 1&2, 2003
Number 5 3&4, 2002	Number 5 1&2, 2002
Number 4 Vol.3 (4), 2000	Number 4 Vol.2 (4), 1999
Number 4 Vol.1 (4), 1998	Number 4 3&4, 2001
Number 4 1&2, 2001	Number 3 Vol.3 (3), 2000
Number 3 Vol.2 (3), 1999	Number 3 Vol.1 (3), 1998
Number 2 Vol.3(2), 2000	Number 2 Vol.1 (2), 1998
Number 2 Vol.2 (2), 1999	Number 1 Vol.3 (1), 2000
Number 1 Vol.2 (1), 1999	Number 1 Vol.1 (1), 1998

About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact